| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/16/2008 | EP1909802A2 Steroidal glycoside compounds as core 2 glcnac-t inhibitors |
| 04/16/2008 | EP1909793A2 Use of phosphodiesterase type 5 inhibitors for the prevention and treatment of diseases or health disorders and dispensing system for said inhibitors |
| 04/16/2008 | EP1909788A2 Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 04/16/2008 | EP1909779A1 Thiol-sensitive positive inotropes |
| 04/16/2008 | EP1909769A2 Alcohol resistant pharmaceutical formulations |
| 04/16/2008 | EP1909763A2 Benzoquinones of enhanced bioavailability |
| 04/16/2008 | EP1909757A2 Oral liquid losartan compositions |
| 04/16/2008 | EP1909572A2 Potassium channel inhibitors |
| 04/16/2008 | EP1833788B1 Process for preparing perindopril erbumine |
| 04/16/2008 | EP1423382B1 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/16/2008 | EP1250155B1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/16/2008 | EP1108039B1 Elongase genes and uses thereof |
| 04/16/2008 | CN101163705A Combination product |
| 04/16/2008 | CN101163700A 三胺衍生物 Triamine derivative |
| 04/16/2008 | CN101163496A Tropoelastin for promoting endothelial cell adhesion or migration |
| 04/16/2008 | CN101163476A Roflumilast for the treatment of pulmonary hypertension |
| 04/16/2008 | CN101161732A Extraction of mangrove kenaelia candel pigment and preparation method and uses thereof |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN101161272A A Chinese medicine for treating apoplexy and its preparing method |
| 04/16/2008 | CN101161270A Pharmaceutical composition of cattail pollen and kudzu root |
| 04/16/2008 | CN101161269A Pharmaceutical composition of cattail pollen or its extract and hawkthorn leaf or its extract |
| 04/16/2008 | CN101161268A Pharmaceutical composition of red sage root and cattail pollen |
| 04/16/2008 | CN101161257A Corydalis total alkali clathrate, its preparing method and application |
| 04/16/2008 | CN101161253A Pharmaceutical composition of melon betel or its extract and safflower or its extract |
| 04/16/2008 | CN101161244A Nimodipine tablet and its preparing method |
| 04/16/2008 | CN101161243A An injection for treating brain apoplexy and its sequela as well as its preparing method |
| 04/16/2008 | CN101161241A Technique of preparing amlodipine besylate tablets |
| 04/16/2008 | CN101161123A A prescription of fruit vegetables juice for dredging vascellum and improving phylactic power as well as its preparing method |
| 04/16/2008 | CN101161117A Nutrition health products with function of decreasing blood pressure and improving cardio-cerebralvascular as well as its preparing method |
| 04/16/2008 | CN100381817C Quality control of compound Danshen root drops |
| 04/16/2008 | CN100381813C Quality control of compound Danshen root drops |
| 04/16/2008 | CN100381462C Peptides and medicinal compositions containing the same |
| 04/16/2008 | CN100381454C Crystalline form of a ribofuranosyluronamide derivative: a human adenosine a2a receptor agonist |
| 04/16/2008 | CN100381446C Aminomethyl-substituted thiazolobenzimidazole derivative |
| 04/16/2008 | CN100381437C Compounds, compositions and methods |
| 04/16/2008 | CN100381436C Flavonoid compound and process for producing the same |
| 04/16/2008 | CN100381435C Extractive of general flavone from blackberry lily, preparation method and application in preparing medication |
| 04/16/2008 | CN100381428C Quinazolone and quinazolone compound and application thereof |
| 04/16/2008 | CN100381168C Use of glucoprotein for pharmaceuticals |
| 04/16/2008 | CN100381163C Medicine comprising rilmenidine |
| 04/16/2008 | CN100381139C Application of pharmaceutical composition in the process for preparing medicine to treat aspirin resistance |
| 04/16/2008 | CN100381135C Application of pharmaceutical composition in the process for preparing medicine to treat aspirin resistance |
| 04/16/2008 | CN100381134C Application of pharmaceutical composition in the process for preparing medicine to treat aspirin resistance |
| 04/16/2008 | CN100381133C Application of pharmaceutical composition in the process for preparing medicine to treat aspirin resisting disease |
| 04/16/2008 | CN100381125C Cardiac and cerebral vascular disease treating medicinal composition |
| 04/16/2008 | CN100381122C Compounding hypotensor contg. amlodipine and atenolol |
| 04/16/2008 | CN100381115C Ginkago leaf oral disintegrating tablet, and its preparing and quality control method |
| 04/15/2008 | US7358386 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358351 Endothelial cell expression patterns |
| 04/15/2008 | US7358342 Preparation derived from shark cartilage for treatment of diseased related to excessive PHF or excessive intracellular calcium |
| 04/15/2008 | US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 04/15/2008 | US7358338 Heme peptide |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358277 an alkali metal or alkaline earth metal lactate salt is useful for simultaneous improvement of the skeleton and/or for the simultaneous prophylaxis and/or treatment of osteoporosis. |
| 04/15/2008 | US7358276 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/15/2008 | US7358273 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases |
| 04/15/2008 | US7358265 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/15/2008 | US7358258 Prodrugs of an ERK protein kinase inhibitor |
| 04/15/2008 | US7358257 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents |
| 04/15/2008 | US7358252 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever |
| 04/15/2008 | US7358240 excellent purity; bradycardic agent; myocardial ischaemia: angina pectoris, myocardial infarct, arrhythmia disturbances, heart failure; structure confirms by X-ray diffraction data; industrial scale, storage stability |
| 04/15/2008 | US7358239 Treating impaired fundic relaxation; [1(R),[A-(3 alpha ,4 alpha )]]-1-[1-[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl]-3-methoxy-4-piperidinyl]-2(1H)-pyrimidinone |
| 04/15/2008 | US7358235 Nitrobenzylthioinosine compounds for relief of pain |
| 04/15/2008 | US7358228 Methods of treating pain using neurotrophic factors |
| 04/15/2008 | US7357336 Generation of therapeutic microfoam |
| 04/15/2008 | CA2566590C Cronotherapeutic diltiazem formulation and the administration thereof |
| 04/15/2008 | CA2410303C Beta-amino acid nitrile derivatives |
| 04/15/2008 | CA2401910C Hydrophilic molecular disperse solutions of carvedilol |
| 04/15/2008 | CA2280629C Carotenoid formulations, comprising a mixture of .beta.-carotene, lycopene and lutein |
| 04/10/2008 | WO2008043081A2 Liquid chalcogenide compositions and methods of manufacturing and using the same |
| 04/10/2008 | WO2008043031A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| 04/10/2008 | WO2008043019A1 8-substituted 2-(benzimidazolyl) purine derivatives for immunosuppression |
| 04/10/2008 | WO2008042968A2 Di-fluoro containing compounds as cysteine protease inhibitors |
| 04/10/2008 | WO2008042796A2 Methods for myocardial imaging in patients having a history of pulmonary disease |
| 04/10/2008 | WO2008042223A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 04/10/2008 | WO2008042174A2 Mesenchymal stem cells and uses therefor |
| 04/10/2008 | WO2008041236A2 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 04/10/2008 | WO2008040986A1 Short peptidic neuropilin-1 antagonists and their use |
| 04/10/2008 | WO2008040974A1 Indoles for use as dpp-iv inhibitors |
| 04/10/2008 | WO2008040774A2 Angiotensin ii receptor antagonist for the treatment of systemic diseases in cats |
| 04/10/2008 | WO2008040764A1 Substituted 4-phenyl piperidines for use as renin inhibitors |
| 04/10/2008 | WO2008040753A1 Indazolyl derivatives useful as potassium channel modulating agents |
| 04/10/2008 | WO2008040651A1 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as hdl-cholesterol raising agents |
| 04/10/2008 | WO2008040649A2 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
| 04/10/2008 | WO2008040367A1 Lercanidipine hydrobromide, a process for its preparation, crystalline forms and compositions thereof |
| 04/10/2008 | WO2008040361A2 Use of a combination of hypothermia inducing drugs |
| 04/10/2008 | WO2008040360A2 Use of hypothermia inducing drugs to treat ischemia |
| 04/10/2008 | WO2008040236A1 Flavones derivatives, preparation methods and uses thereof |
| 04/10/2008 | WO2008011094A3 Cytokine induction of selectin ligands on cells |
| 04/10/2008 | WO2007149451B1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 04/10/2008 | WO2007100833A3 Gpat4 encodes a mammalian, microsomal acyl-coa:glycerol 3-phosphate acyltransferase |
| 04/10/2008 | WO2007092469A3 Combination of organic compounds |
| 04/10/2008 | US20080086000 Prostaglandin reductase |
| 04/10/2008 | US20080085939 Use Of Sphingolipids For Prevention And Treatment Of Atherosclerosis |
| 04/10/2008 | US20080085926 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 04/10/2008 | US20080085923 Thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failure, and cancer; use with other drugs such as aspirin, clodipogrel, prasugrel, cangrelor, Fragmin; himbacine derivatives |
| 04/10/2008 | US20080085914 Administering to a warm-blooded animal a therapeutically effective amount of a renin inhibitor, or a pharmaceutically acceptable salt thereof, for the prevention of, delay progression to overt to, or the treatment of diastolic dysfunction or diastolic heart failure |
| 04/10/2008 | US20080085906 Use raising HDL cholesterol; heart disease; or pyrazine-2-carboxamides; 5-(4-chloro-phenyl)-6-cyclopropylmethoxy-N-((1R,2R)-2-hydroxy-cyclohexyl)-nicotinamide for example |
| 04/10/2008 | US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof |